Glenmark Pharmaceuticals Ltd reports Q2 FY27 revenue of ₹4,247 crore, down 29.8% YoY on a reported basis and up approximately 20% like-for-like
- EBITDA was ₹864 crore, with a 20.3% margin.
- Reported net profit was ₹264 crore; adjusted net profit was ₹485 crore.
- Quarter ended September 30, 2026.